The global Hematopoietic Stem Cells Transplantation market was valued at US$ 2487.2 million in 2022 and is projected to reach US$ 3607.2 million by 2029, at a CAGR of 5.5% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Over 50 years of studies in the field of blood-forming stem cells i.e. hematopoietic stem cells (HSC), researchers have developed significant understanding to use HSCs as a therapy. At present, no type of stem cell, adult, embryonic or fetal has attained such sufficient status. Hematopoietic stem cell transplantation (HSCT) is now routinely used for treating patients with malignant and non-malignant disorders of blood and the immune system. Currently, researchers have observed that through animal studies HSCs have the ability to form other cells such as blood vessels, muscles, and bone.
This report aims to provide a comprehensive presentation of the global market for Hematopoietic Stem Cells Transplantation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hematopoietic Stem Cells Transplantation. This report contains market size and forecasts of Hematopoietic Stem Cells Transplantation in global, including the following market information:
Global Hematopoietic Stem Cells Transplantation Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
Market competition is intense. CBR Systems, China Cord Blood Corporation, ViaCord, Thermo Fisher Scientific, STEMCELL Technologies etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; with the development of society and the changing of consumer demand, there will be more companies enter this industry. Top 5 players accounted for about 32.09% market share.
We surveyed the Hematopoietic Stem Cells Transplantation companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hematopoietic Stem Cells Transplantation Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Hematopoietic Stem Cells Transplantation Market Segment Percentages, by Type, 2022 (%)
- Stem Cells Storage
- Stem Cells Consumables
Global Hematopoietic Stem Cells Transplantation Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Hematopoietic Stem Cells Transplantation Market Segment Percentages, by Application, 2022 (%)
- Leukemia
- Lymphoproliferative Disorders
- Solid Tumors
- Non-Malignant Disorders
Global Hematopoietic Stem Cells Transplantation Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Hematopoietic Stem Cells Transplantation Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Hematopoietic Stem Cells Transplantation revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Hematopoietic Stem Cells Transplantation revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- CBR Systems
- China Cord Blood Corporation
- ViaCord
- Thermo Fisher Scientific
- STEMCELL Technologies
- Vcanbio
- Merck Millipore
- Lonza Group
- CellGenix Technologie Transfer
- ThermoGenesis
Outline of Major Chapters:
- Chapter 1: Introduces the definition of Hematopoietic Stem Cells Transplantation, market overview.
- Chapter 2: Global Hematopoietic Stem Cells Transplantation market size in revenue.
- Chapter 3: Detailed analysis of Hematopoietic Stem Cells Transplantation company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
- Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
- Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
- Chapter 6: Sales of Hematopoietic Stem Cells Transplantation in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
- Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
- Chapter 8: The main points and conclusions of the report.
